Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of November:

• Guggenheim Securities 5th Annual Inflammation, Neurology & Immunology (INI) Conference on Tuesday, November 7, 2023 at 1:10 pm (EST)
• Evercore ISI 6th Annual HealthCONx Conference on Thursday, November 30, 2023 at 12:30 pm (EST)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231018095054/en/

Incyte
Media
[email protected]

Investors
[email protected]

Source: Incyte

You May Also Be Interested In

• Between Old Fuel and a New Frontier: Argonne’s Nuclear Energy Experts Bridges Technology Gaps for Commercialization
• Varda Space Industries Signs Steve Layne as Chief Revenue Officer and Aaron Huber as Chief Financial Officer
• High Computing Power and Rich Multimedia Capabilities With the New Quectel QSM603FCP Smart PCBA